Available Online: Non-Dilutive Funding Opportunities for Cancer R&D Webinar

NIH alone awards roughly $6B annually to Cancer related R&D grants and contracts. The scope of funding support covers much of the R&D cycle with an emphasis on pre-clinical work, and may cover clinical stage activities as well.

In this webinar, we discuss key cancer related opportunities, mainly within the National Cancer Institute (NCI), that are available for life science organizations.

View Slide Deck

/0 Comments/by
You might also like
How Non-Dilutive Funding Can Extend Runway in BioPharma, Biotech, and Tech BioIs Non-Dilutive Funding the Key to Extending Runway in Biopharma and Biotech?
Non-Diltutive Funding Opportunities for Alzheimer’s Disease and Dementia Research
Investing in Digital Health
Reviewing the NIH Review Criteria
SBIR/STTR Programs Could Expire September 30. Reauthorization Opposed by Rand Paul.Webinar on An Introduction to SBIR and STTR Funding Opportunities Now Available Online!
Dr. Natalia Kruchinin is SBIR/STTR Program Coordinator and Director at the National Institute of Allergy and Infectious Disease (NIAID) of the National Institutes of Health. Come hear her speak via livestream, at the 18th Annual Non-Dilutive Funding Summit, Wednesday, January 11, 2023, at the Marines' Memorial Club and Hotel, Union Square, San FranciscoNIAID to Present at NDFS 2023
ARPA-H announces its first funding opportunityARPA-H Announces 1st Funding Opportunities
SBIR/STTR Programs Could Expire September 30. Reauthorization Opposed by Rand Paul.SBIR/STTR Programs Could Expire Sept. 30
0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *